Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

✍ Scribed by Julia M.W. Gee; John F.R. Robertson; Ian O. Ellis; Robert I. Nicholson

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: French
• Weight: 207 KB
• Volume: 95
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/1097-0215(20010720)95:4<247::aid-ijc1042>3.0.co;2-s